SEC 13F Intelligence

Foresite Capital Management IV, LLC / RYTM

Foresite Capital Management IV, LLC’s Rhythm Pharmaceuticals Inc Position

Does Foresite Capital Management IV, LLC own Rhythm Pharmaceuticals Inc (RYTM)? Not currently — the last reported position was 234.5K shares worth $5M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q3 2019
Shares
234.5K
% of Portfolio
+1.64%
Quarters Held
3
position exited

Position History RYTM

Reported value by quarter
Q1 ’19: $11MQ1 ’19Q2 ’19: $10MQ2 ’19Q3 ’19: $5MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2019234.5K$5M+1.64%
Q2 2019469.5K$10M+2.92%
Q1 2019405.0K$11M+3.99%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management IV, LLC’s full portfolio or all institutional holders of RYTM.